Published in Hepatitis Weekly, March 23rd, 1998
According to an article in Obstetrics and Gynecology, both vaccines provide at-risk people over the age of two long-term protection against hepatitis A virus (HAV) infection (Duff and Duff, "Hepatitis A Vaccine: Ready for Prime Time," Obstet Gynecol, March 1998;91(3):468-471). Seroconversion rates exceed 95 percent.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.